Screener
Repligen RGEN D&A
D&A at other companies
Other financials
Where this comes from
Reported directly by Repligen in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The source filing: Repligen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323773
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Net income | $13,341 | $20,696 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 38,824 | 38,785 |
| Amortization of debt discount and issuance costs | 8,833 | 8,158 |
| Loss on sale of business | 13,660 | — |
| Stock-based compensation | 16,335 | 15,648 |
| Deferred income taxes, net | (4,775) | (2,569) |
ITEM 1. Financial Statements
FAQ
- What is Repligen's D&A?
- Repligen (RGEN) reported D&A of $19.06M in Q2 2026.
- How has Repligen's D&A changed year-over-year?
- Repligen's D&A decreased by 5.1% year-over-year, from $20.08M to $19.06M.
- What is the long-term trend for Repligen's D&A?
- Over 4 years (2021 to 2025), Repligen's D&A has grown at a 19.6% compound annual growth rate (CAGR), from $38.45M to $78.75M.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Repligen's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude